Cagrilintide
A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
Novo Nordisk · Phase 1 · Recruiting · Enrollment 100
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Arm 1:Glucose dependent Insulinotropic Polypeptide(GIP)+Cagrilintide then Placebo GIP+Cagrilintide | n/r | n/r | n/r | n/r | n/r |
| Arm 2: Placebo GIP + Cagrilintide then GIP + Cagrilintide | n/r | n/r | n/r | n/r | n/r |
| Arm 3: GIP + Cagrilintide then Placebo GIP + Cagrilintide | n/r | n/r | n/r | n/r | n/r |
| Arm 4: Placebo GIP + Cagrilintide then GIP + Cagrilintide | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.